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Abstract. Erythrocytes have to constantly adapt themselves to the varying circulatory system shear stress forces and capillar-
ies diameter. Membrane lipid and protein content have an important role in determining the erythrocyte shape and are main
determinants of the membrane solid and fluid behaviour which enables the erythrocyte to respond to the outer environment
modifications. Membrane fluidity is an inverse index of membrane microviscosity. The aim of the present work is to evaluate
prospectively in three periods of time (discharge, after 6 months and one year later) in survivors of an acute myocardial infarc-
tion (AMI) the erythrocyte membrane fluidity (outer and inner bilayer) and establish a relation with the cardiovascular events
or need of coronary revascularization during a two year clinical follow up.
Sixty survivors of acute myocardial infarction were recruited during 1994–96 and were prospectively studied in three periods
(discharge, 6 months and after one year), and were compared with a control group (n = 36). Membrane lipid fluidity was de-
termined by means of fluorescence polarisation with two probes: 1,6-diphenyl-1,2,5-hexatriene (DPH) and 1,4-trimethylamine
6-phenyl hexa-1,3,5-triene (TMA-DPH), for the characterisation of the hydrophobic and external polar region, respectively.
The hydrophobic region was more rigidified (p < 0.01) in the erythrocytes from AMI patients, in relation to the control
group. During the time of the study there was a progressive erythrocyte membrane rigidification (DPH p < 0.001; TMA-DPH
p < 0.001). We found no relation between erythrocyte membrane fluidity and the coronary risk factors, cardiovascular events
or the need of coronary revascularization during the clinical follow-up.
In conclusion, after the myocardial infarction erythrocyte membrane of AMI survivors becomes more rigid with time, which
could contribute to the decreased erythrocyte deformability and the increased blood viscosity previously described in this group
of patients.
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1. Introduction
Erythrocytes have a discoid shape that enables them to deform passively when crossing narrow capil-
laries and adapt to the continuous variation of the circulatory system shear stress forces. The capacity to
reversibly change their shape is crucial for the erythrocyte’s oxygen delivery optimisation. Erythrocyte
membrane ultrastructure analysis has revealed that cellular membranes are supramolecular noncovalent
structures with metabolic activity, dynamic and asymmetric properties. They are composed of two main
macromolecules: phospholipid bilayer and membrane proteins.
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The erythrocyte membrane plays a critical role in determining both cell shape and its ability to deform,
however transmembrane, cytoskeleton, and cytoplasmatic proteins as well as lipids are major determi-
nants of the functional regulatory process [1,2].
The lipid and protein mobility is another important factor for the dynamic properties of RBC mem-
brane. The association of the solid and fluid behaviour of both protein and lipid was responsible for
membrane viscoelastic properties [3], which are prime determinants of the erythrocyte’s deformability.
Proteins are responsible for membrane elastic properties while viscous properties are influenced by lipid
microviscosity [4].
Membrane lipid fluidity is an indirect and inverse index of membrane’s microviscosity and lipid mo-
bility, being influenced by several substances such as anesthetics [5], anti-arrhythmic drugs [6], and
insulin [7]. In addition, it has been implicated in the modulation of several functions of the erythro-
cyte membrane, such as (i) increased permeability to sodium with decreasing microviscosity [8], (ii) de-
creased erythrocyte deformability with increasing microviscosity [9], and (iii) limitation of protein lateral
mobility with increased membrane microviscosity [10].
Patients survivors of acute myocardial infarction are at risk for new ischemic events such as angor,
reinfarction, stroke; which may be associated with microcirculatory and hemorheological abnormalities,
such as increased whole blood viscosity [11], increased plasma viscosity [11], decreased erythrocyte
deformability at low shear stress forces [12], and erythrocyte membrane rigidity [13] that have been
described at hospital discharge. These abnormalities have been associated with AMI survivors’ long-
term clinical prognosis [14].
Besides the detected hemorheological abnormalities during the acute phase of an AMI and in patients
with coronary artery disease, we still do not know how the profile evolves after the patients’ hospital
discharge.
The aim of the present work is to prospectively evaluate erythrocyte membrane fluidity variation in
three periods of time (discharge, 6 months and after one year) in a group of survivors of an acute myocar-
dial infarction (AMI) proceeding from a coronary unit and study a possible relation with new ischemic
events or the need of coronary revascularization. The results are to be compared with a control population
of blood donors.
2. Material and methods
Population. Sixty survivors of an AMI (51 men and 9 women) mean age 57.9 ± 12.2 years old were
recruited during 1994–96 from a hospital coronary unit and prospectively studied in three periods of
time: hospital discharge (n = 60), after 6 months (n = 47) and one year later (n = 30). The control
group was constituted by 36 apparently healthy subjects (24 men and 12 women) mean age of 45.6 ±
9.8 years old, blood donors of the Hospital Santa Maria blood centre.
Vascular events definition. Two groups of events were collected: (i) vascular events (death, angor, AMI,
cardiac failure and stroke) or (ii) need of coronary revascularization (patients submitted to elective coro-
nary aortocoronary bypass and percutaneous coronary angioplasty). These data were processed sepa-
rately and in association (these patients were considered to be at higher risk).
Methods. Erythrocyte membrane fluidity was evaluated by measuring fluorescence polarisation using
two fluorescent probes: 1,6-diphenyl-1,2,5-hexatriene (DPH) and 1,4-trimethylamine 6-phenyl hexa-
1,3,5-triene (TMA-DPH) for the characterisation of the hydrophobic and external polar region of the
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phospholipid bilayer, respectively [15,16]. A spectrophluorometer Hitachi FL 300 was used. Higher val-
ues of the fluorescence polarisation mean lower membrane fluidity, thus higher microviscosity or rigidity.
Statistical analysis. The variation during the time of the study and between groups comparisons were
determined with ANOVA variance analysis with the Bonferroni correction. Paired t-test was used for
paired comparisons. A 0.05 significant level was considered.
3. Results
3.1. Comparison between erythrocyte membrane fluidity in the control group and AMI survivors
(discharge, after 6 months and one year later)
There was no significant variation in the values of the fluorescence polarisation for the external polar
region, between the control group and the AMI patients in the three periods of time.
However, the values of the fluorescence polarisation for the DPH probe were higher (p < 0.01) in the
AMI survivors (for the three periods of time) in relation to the control group. Therefore, the erythrocytes
from AMI survivors at discharge, after 6 months and one year later have a more rigidified hydrophobic
bilayer than the erythrocytes from apparently healthy subjects.
3.2. Erythrocyte membrane fluidity variation during the three periods of time (discharge, after
6 months and one year later) in AMI survivors
There was a significant variation of the fluorescence polarisation values of the DPH (p < 0.001)
and TMA-DPH (p < 0.001) probes during the time of the study determined with ANOVA analysis of
variance. By the Bonferroni correction for multiple group comparison we determined that the previous
time-dependent variation was mainly determined by the difference between the discharge values and
the two other determinations (at 6 months and after one year). We found no significant difference be-
tween the sixth month and the one-year later determination. So the erythrocyte membrane (hydrophobic
and external polar bilayers) fluidity increased (rigidified) abruptly after discharge and stabilised after 6
months.
3.3. Erythrocyte membrane fluidity relation with the coronary risk factors in AMI survivors
Fifteen percent of the patients had no coronary risk factors (Table 1). We found no significant relation
between erythrocyte membrane fluidity and the previous coronary risk factors or the number of risk
factors.
3.4. Erythrocyte membrane fluidity relation with coronary events and need of coronary
revascularization
During the time of this study there was a total of 17 cardiovascular events, 19 patients needed coronary
revascularization (11 bypass surgery and 8 angioplasty) and one patient died.
There was no statistical difference in the erythrocyte membrane fluidity determined at hospital dis-
charge for the patients who had cardiovascular events and/or need of coronary revascularization. Never-
theless, those who had cardiovascular events during the clinical follow-up had marginally (p = 0.049)
higher values of the membrane fluorescence polarisation concerning the TMA-DPH at the sixth month
determination.
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Table 1
Clinical profile of acute myocardial infarction survivors
N = 60
Sex: 51 men; 9 women
Age: 57.9 ± 12.2 years
Risk factors Angor 41.7%
Previous AMI 16.7%
Diabetes 13.3%
Art. hypertension 50.0%
Smoking 38.3%
Risk factors by patient 0. . .14.7% 2. . .33.7%
1. . .34.7% 3. . .14.7%
Infarction location Anterior 40%
Inferior 41%
Killip class 1 . . . 76.8%
2 . . . 15.8%
Thrombolysis 37.9% (27 with reperfusion criteria)
Table 2
Values (mean ± SD) of red cell membrane fluorescence polarisation (assessed by two fluorescence probes:
DPH and TMA-DPH) in a control group and in survivors of an acute myocardial infarction (AMI) at hospital
discharge, after 6 and 12 months later (see text for more details). There was a significant variation of the
erythrocyte membrane fluidity in the AMI patients during the time of the study (discharge, after 6 months and
one year later)
Probes Membrane fluorescent polarisation (p)* Significance level**
Control Discharge 6 months 12 months
group
DPH 0.267 ± 0.03 0.298 ± 0.022 0.318 ± 0.022 0.309 ± 0.025 0.001
TMA-DPH 0.325 ± 0.023 0.312 ± 0.027 0.337 ± 0.015 0.333 ± 0.023 0.001
*Fluorescence polarisation value (see material and methods for details). **Variation during the time of the
study (discharge, 6 months and one year later).
Fig. 1. Erythrocyte membrane fluorescence polarisation (p) in a control group and in acute myocardial infarction survivors
determined in three periods of time (hospital discharge, 6 months later and after one year). The fluorescence polarisation values
for the DPH probe, which characterises the membrane hydrophobic region, were higher (p < 0.01) in the acute myocardial
infarction survivors (for the three determinations) than the control group.
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4. Discussion
Our group of acute myocardial infarction survivors exhibits at discharge, in relation to the control
group, erythrocyte inner membrane rigidification, and no variation of the external polar region fluidity.
This asymmetric behaviour of the erythrocyte membrane fluidity could be related with erythrocyte mem-
brane interaction with plasma proteins, such as acute phase reactants. We did not find any relation of the
erythrocyte membrane fluidity with the patients therapeutics (in the hospital and after).
After hospital discharge there was a progressive raise of the fluorescence polarisation values in both
membrane layers. So, the erythrocyte membrane becomes rigidified. Nevertheless, only the hydrophobic
region was more rigid in the erythrocytes from AMI in relation to the control group during the three
periods.
This finding could explain the previous reported decreased erythrocyte deformability at low shear
stress [12] in AMI survivors at hospital discharge. Erythrocyte deformability at low shear stress is mainly
dependent on the erythrocyte membrane rigidity [9,17]. In addition, it could contribute to the erythrocyte
aggregation impairment. Nevertheless, these finding could be related to the fibrinogen high concentration
seen in these patients. However, it has been reported that fibrinogen concentration lowers after hospital
discharge while erythrocyte aggregation increases after hospital discharge [11]
Apparently, no statistical differences were determined for the erythrocyte membrane fluidity in the
patients who developed any cardiovascular events or who had previous coronary risk factors. These ob-
servations could be related with the small population number or to the small follow-up time. In addition,
we found no relation with the patients’ cardiovascular risk factors.
In conclusion, this group of acute myocardial infarction survivors, independently of their previous
cardiac risk factors and the future development of cardiac events, has rigidified erythrocyte membrane
in relation to a reference population. The fluorescence polarisation value for the two probes tends to in-
crease over time, indicating a progressive erythrocyte membrane rigidification process. The present study
helps to interpret the evolution of the erythrocyte membrane fluidity in survivors of an acute myocardial
infarction, during three periods: discharge, after 6 months and one year later.
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